Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine transdermal patch observational study in chronic pain due to osteoarthrosis and related musculoskeletal disorders
ChiCTR-OPC-17013583Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Dec 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of buprenorphine in osteoarthritis (OA), Sacroiliitis (SIJ), ankylosing spondylitis (AS) and 1 more, sponsored by West China Hospital of Sichuan University. Primary endpoint: Change in average pain intensity over 24 hours from baseline to final evaluation. Planned start Dec 2017; status: not yet recruiting.
02
Drugs
buprenorphine
03
Conditions
osteoarthritis (OA)Sacroiliitis (SIJ)ankylosing spondylitis (AS)chronic myofascial pain (CMP)
Beyond the preview
Go deeper on ChiCTR-OPC-17013583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-17013583.